Although proton pump inhibitors (PPI) are generally well tolerated, with most adverse effects being minor and self-limiting, there are singular reports on hypersensitivity immune reactions triggered by a PPI or its metabolites. Here we report a case of acute drug-induced fever with leukocytosis and a transient increase in CRP due to pantoprazole. This was apparently an idiosyncratic reaction (inflammatory fever), showing no cross-sensitivity towards esomeprazole.

Shi S, Klotz U: Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol 2008;64:935-951.
Thomson AB, Sauve MD, Kassam N, Kamitakahara H: Safety of the long-term use of proton pump inhibitors. World J Gastroenterol 2010;16:2323-2330.
Mouli VP, Ahuja V: Proton pump inhibitors: concerns over prolonged use. Trop Gastroenterol 2011;32:175-184.
Ra A, Tobe SW: Acute interstitial nephritis due to pantoprazole. Ann Pharmacother 2004;38:41-45.
Brewster UC, Perazella MA: Acute kidney injury following proton pump inhibitor therapy. Kidney Int 2007;71:589-593.
Klassen S, Krepinsky JC, Prebtani AP: Pantoprazole-induced acute interstitial nephritis. CMAJ 2013;185:56-59.
Landray MJ, Ringrose T, Ferner RE, Arnold IR: Pyrexia, anaemia and acute renal failure secondary to omeprazole. Postgrad Med J 1998;74:416-422.
Grattagliano I, Portincasa P, Mastronardi M, Palmieri VO, Palasciano G: Esomeprazole-induced central fever with severe myalgia. Ann Pharmacother 2005;39:757-760.
Cheng FC, Ho YF, Hung LC, Chen CF, Tsai TH: Determination and pharmacokinetic profile of omeprazole in rat blood, brain and bile by microdialysis and high-performance liquid chromatography. J Chromatogr A 2002;949:35-42.
Smyth EM, Grosser T, Wang M, Yu Y, FitzGerald GA: Prostanoids in health and disease. J Lipid Res 2009;50:S423-S428.
Kepil Özdemir S, Yılmaz I, Aydin Ö, Büyüköztürk S, Gelincik A, Demirtürk M, Erdoğdu D, Cömert S, Erdoğan T, Karakaya G, Kalyoncu AF, Oner Erkekol F, Dursun AB, Misirligil Z, Bavbek S: Immediate-type hypersensitivity reactions to proton pump inhibitors: usefulness of skin tests in the diagnosis and assessment of cross-reactivity. Allergy 2013;68:1008-1014.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.